Clinical outcomes and markers of treatment response in a randomized phase II study of androgen deprivation therapy with or without palbociclib in RB-intact metastatic hormone-sensitive prostate cancer (mHSPC).

Authors

null

Phillip Lee Palmbos

University of Michigan Rogel Cancer Center, Ann Arbor, MI

Phillip Lee Palmbos , Scott A. Tomlins , Stephanie Daignault , Neeraj Agarwal , Przemyslaw Twardowski , Alicia K. Morgans , William Kevin Kelly , Vivek Arora , Emmanuel S. Antonarakis , Javed Siddiqui , Dan Robinson , Karen E. Knudsen , Arul Chinnaiyan , Maha H. A. Hussain

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer - Advanced Disease

Clinical Trial Registration Number

NCT02059213

Citation

J Clin Oncol 38: 2020 (suppl; abstr 5573)

DOI

10.1200/JCO.2020.38.15_suppl.5573

Abstract #

5573

Poster Bd #

154

Abstract Disclosures

Similar Posters

Poster

2020 ASCO Virtual Scientific Program

Genomic landscape and immune phenotype of malignant pleural mesothelioma.

Genomic landscape and immune phenotype of malignant pleural mesothelioma.

First Author: Meera Patel